{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-014093","form_type":"8-K","ticker":"LMAT","cik":"0001158895","company_name":"LEMAITRE VASCULAR INC","filed_at":"2025-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.664056+00:00","generated_at":"2026-05-22T23:45:30.047549+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LeMaitre Vascular Q1 sales $59.9M (+12% YoY), raises FY guidance, declares $0.20 dividend","bullets":["Q1 sales $59.9M, +12% reported (+13% organic); EPS $0.48, +10% YoY.","FY 2025 sales guidance raised to $242-249M (mid $245M, +13% organic) from prior $239M.","Quarterly dividend of $0.20/share declared, payable May 29 to holders of record May 15.","Artegraft received MDR CE Mark on April 29; European launch to begin.","Ended Elutia porcine patch distribution agreement on April 30 (U.S. hospital sales $5.0M in 2024)."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-014093","json":"https://secwatch.observer/filing/0001437749-25-014093.json","markdown":"https://secwatch.observer/filing/0001437749-25-014093.md","text":"https://secwatch.observer/filing/0001437749-25-014093.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158895/000143774925014093/0001437749-25-014093-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158895/000143774925014093/lmat20250501_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T23:45:30.047549+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}